UK High Court rules Roche patent is invalid

The English High Court has ruled that a patent owned by Roche should be revoked on grounds of insufficiency.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Generics

UK High Court upholds Alcon glaucoma patent

27 April 2021 The UK High Court has refused to invalidate an Alcon glaucoma treatment patent in a judgment handed down on Friday, April 23.

Big Pharma

Roche enters $200m hep B treatment collaboration

31 October 2019 Roche has entered into a $200 million agreement to licence Dicerna’s GalXC RNAi platform technology to develop novel therapies for the treatment of chronic hepatitis B.

Big Pharma

Amgen and Roche target Samsung’s Bioepis in patent suit

1 May 2019 Amgen and Roche have filed a joint patent infringement claim against Samsung’s biopharmaceutical company Bioepis.

More on this story

Generics

UK High Court upholds Alcon glaucoma patent

27 April 2021 The UK High Court has refused to invalidate an Alcon glaucoma treatment patent in a judgment handed down on Friday, April 23.

Big Pharma

Roche enters $200m hep B treatment collaboration

31 October 2019 Roche has entered into a $200 million agreement to licence Dicerna’s GalXC RNAi platform technology to develop novel therapies for the treatment of chronic hepatitis B.

Big Pharma

Amgen and Roche target Samsung’s Bioepis in patent suit

1 May 2019 Amgen and Roche have filed a joint patent infringement claim against Samsung’s biopharmaceutical company Bioepis.

More on this story

Generics

UK High Court upholds Alcon glaucoma patent

27 April 2021 The UK High Court has refused to invalidate an Alcon glaucoma treatment patent in a judgment handed down on Friday, April 23.

Big Pharma

Roche enters $200m hep B treatment collaboration

31 October 2019 Roche has entered into a $200 million agreement to licence Dicerna’s GalXC RNAi platform technology to develop novel therapies for the treatment of chronic hepatitis B.

Big Pharma

Amgen and Roche target Samsung’s Bioepis in patent suit

1 May 2019 Amgen and Roche have filed a joint patent infringement claim against Samsung’s biopharmaceutical company Bioepis.